glp-1 drug use before pregnancy is linked to some risks. Understanding the Risks of Medications During New Analysis: GLP-1 Drugs in

That is lower than many tirzepatide starting dose protocols

These agents include: Liraglutide (Victoza, Saxenda) once-daily injection Semaglutide (Ozempic, Wegovy) once-weekly Tirzepatide (Mounjaro) a dual GLP-1/GIP agonist From Glycaemic Control to Weight Regulation GLP-1RAs were initially licensed to lower HbA1c in people with Type 2 diabetes, offering an alternative to sulfonylureas and insulin

To ease potential side effects, begin with a lower dose and slowly increase it, allowing your body time to adapt

Improved metabolic markers Tirzepatide improves blood sugar control, insulin sensitivity, and inflammatory markers

Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation

Researchers found that patients who achieved the greatest reductions in body weight after starting GLP-1-based medications had substantially lower risks of conditions including obstructive sleep apnea, chronic kidney disease, osteoarthritis, and heart failure